Press

Revitalist and Wake Network Announce Joint Venture Partnership to Open Psychedelic Clinics and Retreats in the United States

Nov 14 • 3 min read

Revitalist Lifestyle and Wellness LTD. (CSE: CALM | OTCQB: RVLWF) (FSE: 4DO), Revitalist and WAKE Network, Inc. announce the joint venture partnership opening psychedelic clinics and retreats with vertical offerings with a personalized medicine and therapy approach. Revitalist continues to establish its presence as a first full-service psychedelic wellness clinic offering ketamine infusions, therapy, integrative…

Psychedelic-Assisted Therapy Company Better U Creates Military Liaison Officer Position to Help Expand Access to Veterans

Nov 14 • 4 min read

In honor of Veteran’s Day, Better U, a leading psychedelic therapy company celebrated for its unique integrative care model, is proud to announce that Tyler Hare, an Air Force veteran, as their Military Liaison to help increase access and educational outreach for veterans. “Working with the military community is unique because there is less stigma around mental health….

TRIPSITTER CLINIC LTD. ANNOUNCES THE CLOSING OF ASSETS ACQUISITION DEAL WITH RECONCIOUS MEDICAL AND APPOINTMENT OF DR. MARK BRAUNSTEIN AS CHAIRMAN

Nov 14 • 3 min read

TripSitter Clinic Ltd. (CSE: KETA | FSE: UY0), further to the press release dated Mar 22, 2022, today announced the closing of the acquisition of assets of Insight Systems, PBC doing business as Reconscious Medical. The assets of Reconscious Medical will be instrumental in the future growth plans of the Company. Reconscious Medical is a psychedelic…

IntelGenx Reports Third Quarter 2022 Financial Results

Nov 11 • 4 min read

IntelGenx Technologies Corp. (TSX:IGX | OTCQB:IGXT) today reported financial results for the third quarter ended September 30, 2022. All dollar amounts are expressed in U.S. currency, unless otherwise indicated, and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise. 2022 Third Quarter Financial Summary: Revenue was $142,000, compared to $593,000 in the 2021…

Small Pharma to Participate in November Investor and Healthcare Conferences

Nov 11 • 2 min read

Small Pharma Inc. (TSXV: DMT | OTCQB: DMTTF) , a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce its participation in the following upcoming conferences in November. Jefferies London Healthcare Conference, November 15-17 George Tziras, Chief Executive Officer of the Company, will participate in a fireside chat on…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435